| |
| |
|
| Insider
Information: |
Virgin Herbert |
| Relationship: |
EVP, Research & CSO |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
262,500 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
262,500 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vir Biotechnology, Inc. |
VIR |
EVP, Research & CSO |
2022-08-09 |
262,500 |
2020-05-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-08-09 |
4 |
OE |
$1.53 |
$189,658 |
D/D |
78,093 |
262,500 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
175,407 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-01-26 |
4 |
OE |
$1.53 |
$47,889 |
D/D |
31,300 |
64,500 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-01-26 |
4 |
AS |
$48.17 |
$1,507,806 |
D/D |
(31,300) |
33,200 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
63,200 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-08-25 |
4 |
OE |
$1.53 |
$39,107 |
D/D |
25,560 |
25,560 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-02-23 |
4 |
OE |
$1.53 |
$28,917 |
D/D |
18,900 |
82,100 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-04-09 |
4 |
OE |
$1.53 |
$21,420 |
D/D |
14,000 |
88,200 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-08-23 |
4 |
OE |
$1.53 |
$21,038 |
D/D |
13,750 |
113,450 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-08-23 |
4 |
AS |
$50.00 |
$687,500 |
D/D |
(13,750) |
99,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-01-15 |
4 |
OE |
$1.53 |
$16,111 |
D/D |
10,530 |
43,730 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-01-15 |
4 |
AS |
$38.00 |
$400,140 |
D/D |
(10,530) |
33,200 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-12-24 |
4 |
OE |
$1.53 |
$14,535 |
D/D |
9,500 |
33,200 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-06-24 |
4 |
OE |
$1.53 |
$14,321 |
D/D |
9,360 |
9,360 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-06-24 |
4 |
AS |
$48.00 |
$449,280 |
D/D |
(9,360) |
0 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2022-03-10 |
4 |
OE |
$1.53 |
$13,770 |
D/D |
9,000 |
184,407 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-06-23 |
4 |
OE |
$1.53 |
$12,240 |
D/D |
8,000 |
99,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-09-22 |
4 |
OE |
$1.53 |
$12,240 |
D/D |
8,000 |
107,700 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-07-14 |
4 |
OE |
$1.53 |
$12,087 |
D/D |
7,900 |
7,900 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-07-14 |
4 |
AS |
$48.85 |
$385,876 |
D/D |
(7,900) |
0 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-07-28 |
4 |
AS |
$47.99 |
$379,090 |
D/D |
(7,900) |
0 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-07-28 |
4 |
OE |
$1.53 |
$12,087 |
D/D |
7,900 |
7,900 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-08-11 |
4 |
OE |
$1.53 |
$12,087 |
D/D |
7,900 |
7,900 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2020-08-11 |
4 |
AS |
$51.08 |
$403,563 |
D/D |
(7,900) |
0 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
EVP, Research & CSO |
• – – |
2021-02-09 |
4 |
OE |
$1.53 |
$12,087 |
D/D |
7,900 |
41,100 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
